Product image of ZEPBOUND 10mg/0.5ml (Tirzepatide) 10mg/0.5ml Vials supplied by GNH India

ZEPBOUND 10mg/0.5ml

Active Ingredient:
Tirzepatide
Form:
Vials
Brand:
ZEPBOUND
Origin:
USA

ZEPBOUND 10mg/0.5ml (Tirzepatide Vials) 10mg/0.5ml

Tirzepatide, the active ingredient in Zepbound 10mg/0.5ml, is a GIP/GLP-1 receptor agonist presented as a 10mg/0.5ml injectable solution in vials for subcutaneous use. It is indicated for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.

GNH India supplies Zepbound 10mg/0.5ml as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Strength

10mg/0.5ml

Pack Size

4s

Storage

2-8°

Manufacturer / TM Owner

LILLY ELI & CO

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Zepbound 10mg/0.5ml is a GIP/GLP-1 receptor agonist used in the management of obesity and related conditions. It is indicated for:

  • Obesity: To help adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity achieve and maintain weight loss.
  • Moderate-to-severe obstructive sleep apnea (OSA): To improve OSA in adults with obesity.
  • Type 2 diabetes: To improve glycemic control in adults with type 2 diabetes.

How It Works

  • Zepbound 10mg/0.5ml works by activating both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action enhances insulin secretion, suppresses glucagon secretion, slows gastric emptying, and reduces appetite, leading to significant and sustained weight loss.

Side Effects

Zepbound 10mg/0.5ml may cause various side effects, which can be categorized as common or serious.

Common Side Effects

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Injection site reactions
  • Fatigue
  • Hypersensitivity reactions
  • Hair loss
  • Gastroesophageal reflux disease

Serious or Rare Side Effects

  • Tumors in the thyroid, including thyroid cancer
  • Pancreatitis
  • Gallbladder problems
  • Hypoglycemia (low blood sugar)
  • Kidney problems
  • Allergic reactions
  • Increased risk of suicidal thoughts or behavior

Precautions & Warnings

Zepbound 10mg/0.5ml should be used with caution and under the supervision of a healthcare provider. Important precautions include:

  • Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Monitor for symptoms of thyroid tumors, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath.
  • Use with caution in patients with a history of pancreatitis or gallbladder problems.
  • Monitor blood sugar levels regularly, especially in patients with type 2 diabetes.
  • Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Zepbound 10mg/0.5ml may interact with other medications, which can be categorized as major or moderate interactions.

Major Interactions (Avoid)

  • Other tirzepatide-containing products
  • GLP-1 receptor agonist medicines
  • Insulin or other antidiabetic medications
  • Oral medications that require rapid gastric emptying for absorption

Moderate Interactions (Monitor Closely)

  • Medications that increase the risk of hypoglycemia
  • Medications that affect gastrointestinal motility
  • Medications that are metabolized by the liver or kidneys

Frequently Asked Questions

Zepbound 10mg/0.5ml is used for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. It is also used to improve moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity and to improve glycemic control in adults with type 2 diabetes.

Tirzepatide, the active ingredient in Zepbound 10mg/0.5ml, works by activating both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action enhances insulin secretion, suppresses glucagon secretion, slows gastric emptying, and reduces appetite, leading to significant and sustained weight loss.

The usual dose of Zepbound 10mg/0.5ml is determined by a healthcare provider based on individual patient needs and response to treatment. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider.

The safety of Zepbound 10mg/0.5ml during pregnancy or breastfeeding has not been established. It is important to consult with a healthcare provider before using this medication if you are pregnant, planning to become pregnant, or breastfeeding.

To order Zepbound 10mg/0.5ml from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping, and the import paperwork.

Zepbound 10mg/0.5ml is a dual GIP/GLP-1 receptor agonist, which sets it apart from other weight loss medications that may only target one of these receptors. Its unique mechanism of action can lead to more significant and sustained weight loss compared to other medications.

Zepbound 10mg/0.5ml should be stored at 2-8°C, kept refrigerated, protected from light, and not frozen or shaken. It is important to follow the storage and handling instructions provided with the medication to ensure its effectiveness and safety.

Zepbound 10mg/0.5ml is administered as a subcutaneous injection once weekly. The injection can be given in the stomach (abdomen), thigh, or back of the upper arm. It is important to rotate the injection site with each weekly injection and not to inject into a muscle or vein.

The most serious risks to watch for with Zepbound 10mg/0.5ml include tumors in the thyroid, including thyroid cancer, pancreatitis, gallbladder problems, hypoglycemia (low blood sugar), kidney problems, allergic reactions, and increased risk of suicidal thoughts or behavior. It is important to monitor for these risks and consult with a healthcare provider if any symptoms occur.

Zepbound 10mg/0.5ml should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It should also not be used by individuals who have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound 10mg/0.5ml.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tirzepatide

MOUNJARO 2.5mg

MOUNJARO 2.5mg

2.5mgx0.5ml PFS
MOUNJARO 5mg

MOUNJARO 5mg

5mgx0.5ml PFS
MOUNJARO 7.5mg

MOUNJARO 7.5mg

7.5mgx0.5 ml PFS
MOUNJARO 10 mg

MOUNJARO 10 mg

10 mgx0.5 ml PFS

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT